Showing results (71-80 of 89) with videos related to
Sort By:
Pageof 9
Chest|February 3, 2016
Lung Function Trajectories in World Trade Center-Exposed New York City Firefighters Over 13 Years: The Roles of Smoking and Smoking CessationThomas K Aldrich, Madeline Vossbrinck, Rachel Zeig-Owens, et al.Research Square|May 27, 2024
Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BAD-BURN): a Case-Control Observational Study ProtocolUrooj Javed, Sanjiti Podury, Sophia Kwon, et al.BMC Gastroenterology|August 9, 2024
Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BAD-BURN) in World Trade Center exposed firefighters: a case-control observational study protocolUrooj Javed, Sanjiti Podury, Sophia Kwon, et al.Lung|May 7, 2024
Interstitial Lung Disease and Progressive Pulmonary Fibrosis: a World Trade Center Cohort 20-Year Longitudinal StudyKrystal L Cleven, Rachel Zeig-Owens, Alexandra K Mueller, et al.American Journal of Industrial Medicine|June 22, 2013
The respiratory pyramid: From symptoms to disease in World Trade Center exposed firefightersJustin K Niles, Mayris P Webber, Hillel W Cohen, et al.Plos Currents|June 12, 2015
The Duration of an Exposure Response Gradient between Incident Obstructive Airways Disease and Work at the World Trade Center Site: 2001-2011Charles B Hall, Xiaoxue Liu, Rachel Zeig-Owens, et al.Plos One|July 21, 2012
Comparison of WTC dust size on macrophage inflammatory cytokine release in vivo and in vitroMichael D Weiden, Bushra Naveed, Sophia Kwon, et al.The Journal of Pharmacology and Experimental Therapeutics|March 3, 2009
Enhanced gastrointestinal motility with orally active ghrelin receptor agonistsSoratree Charoenthongtrakul, Derek Giuliana, Kenneth A Longo, et al.American Journal of Industrial Medicine|June 6, 2014
The upper respiratory pyramid: early factors and later treatment utilization in World Trade Center exposed firefightersJustin K Niles, Mayris P Webber, Xiaoxue Liu, et al.The Journal of Pharmacology and Experimental Therapeutics|July 22, 2011
Pharmacologic inhibition of ghrelin receptor signaling is insulin sparing and promotes insulin sensitivityKenneth A Longo, Elizabeth K Govek, Anna Nolan, et al.Pageof 9